Hot! The Official Nike Foamposite For Paranorman Fans, Proving That Weird Wins

I sure did not see this coming. Shoe giant and marketing genius Nike has developed the Paranorman Nike Foamposite to plug the release of the stop action flick. While sneaky co-branding from the company isn’t a rarity (ie Heineken and Jagermeister Dunk SB’s), this time it’s official. The focus of the Paranorman movie is one “oddball” child’s fight to save the world from an army of zombies and to gain the respect of his peers. While ridding the world of the undead is something we can get behind, the additional concept behind these Foams is definitely a great one. The green smoke on the side panels leading to a neon green glow in the dark soul definitely give off the “zombies rising from the fog” vibe.

 

The heel logo on the left shoe shows Norman’s silhouette and the pull tabs state the mantra of weird kids worldwide: Weird Wins. Damn right. A clear message is given through the movie and now from Nike that being weird is perfectly ok. Hell, when I was a child, we had a lot of damn weirdos in my school. We called them teachers. Trying to teach us useful things, wtf were they thinking? Norman personifies the nerd we all knew growing up that everyone though was too weird to be classified as “cool.” What Nike’s accomplishing with this special edition shoe is sending the message out that weird doesn’t have to be a bad thing. So the next time you see a weird kid, be kind to them. They may just save the world from zombies. That whole phrase “the meek shall inherit the earth” has stood the test of time for a reason.

There’s only 800 pairs of these available, and none are for sale. To win them, you’ve got to follow the Paranorman twitter, tweet a photo of yourself as a weird kid to them, and include the hashtag #weirdwins to be entered. Time to start digging through childhood photos people.

For more details visit: The Foamposite Paranorman Site

Author

J Brooks

J Brooks is sound asleep somewhere because he thought Tylenol PM stood for "Power Medicine."